Patents Assigned to SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO., LTD.
  • Polycyclic substituted pyrazole kinase activity inhibitors and use thereof
    Patent number: 9550792
    Abstract: The present invention relates to the field of medicinal chemistry, and in particular relates to 4-(five-membered heterocyclic pyrimidine/pyridine substituted) amino-1H-3-pyrazolecarboxamide derivatives, the preparation method thereof, pharmaceutical compositions containing these compounds and the medicinal use thereof, especially as protein kinase inhibitors for anti-tumor use.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: January 24, 2017
    Assignee: SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO., LTD.
    Inventors: Tao Lu, Yue Wang, Yadong Chen, Yi Lu, Zhanwei Wang, Qiaomei Jin, Taotao Yang, Guowu Lin, Qinglong Guo, Li Zhao